Background: Diabetes mellitus and hyperlipidemia are the most common metabolic disorder affecting the people all over the world. Hyperglycemia is considered a primary cause of diabetic vascular complications and is associated with impaired electrolytes in some of the metabolic dysfunctions is not clear. Aim: The purpose of this study was conducted to investigate the relationship among diabetes mellitus, lipid profi les and electrolytes (Na + , K + and Cl -). Methods: In the sera of 85 non insulin-dependent diabetes mellitus NIDDM, 45 with hyperlipidemia, 40 without hyperlipidemia, 50 samples of hyperlipidemia without NIDDM,and 50 non diabetic healthy control subjects. The mean age of the diabetic patients was similar to that of control.The mean duration of the disease was (10.2±5.9) years (2-23) years. From the results, it was discovered that there was a signifi cant decrease in Na + and Clin patients with NIDDM without high level of lipid profi le (group I), but our results show that the concentration of K + not changed signifi cantly. The plasma levels of Na + and Clions were show signifi cant change in patient with hyperlipidemia without NIDDM (group II), while plasma K + not changed signifi cantly in this group as compared with control. The mean value of Na + and Clshow high signifi cant change in NIDDM patients with high level of lipids profi le (group III),were plasma K + not changed signifi cantly as compared with control group. Conclusion: These fi nding may explain the role of impaired electrolytes status in NIDDM and hyperlipidemia subjects.
INTRODUCTION
Diabetes mellitus DM is heredity, chronic and endocrine metabolic disorder which causes death worldwide. 1 Type 2 diabetes is associated with cluster of interrelated plasma lipid and lipoprotein abnormalities, including reduced HDL cholesterol, predominance of small density LDL particles and elevated triglycerides. 2, 3 There are probably 100 million people in the world with diabetes mellitus and incidences of diabetes are on the rise. As diabetes progress patients are at increased risk of developing coronary disease. 4, 5 NIDDM is directly linked with dyslipidemia due to the lack of effect of insulin. Altered atherogenic lipoprotein pattern and elevation of some liver enzymes have been identifi ed as independent risk factors for the development of cardiovascular disease along with prevalence of liver enzymes abnormality ranging from 7.2 to 22.9% in patients of NIDDM. [6] [7] [8] Infact, pre-diabetic individuals often exhibit an atherogenic pattern of risk factors that includes higher levels of total cholesterol, LDL cholesterol, triglycerides and lower levels of HDL cholesterol than individuals who do not develop diabetes. 9, 10 In case where a disease such as diabetes disrupts metabolic function, the body's electrolyte control system is broken down. The results of electrolyte imbalance can be severe.
In diabetic out patients, acid-base and electrolyte disorders occurred often even if the renal function is normal, and the most common disorders are metabolic alkalosis and metabolic acidosis, in addition, the common electrolyte disorders are hypernatremia and hypokalemia. 11
MATERIALS AND METHODS
This study was conducted at the department of chemistry, Faculty of Science with collaboration of Central Medical Lab in Suliamania city, Kurdistan region/Iraq.
The study group
This study was conducted on 3 groups: group I, II and III. The patients were diagnosed on the basis of detailed clinical history, clinical examination and other relevant biochemical investigations. The patients suffering from other diseases, such as diabetes, infl ammatory diseases, hepatic impairment, cardiac diseases and other systemic diseases. Fasting venous blood were drawn from all.
Collection of blood samples
After an overnight fasting of 10-12 hours, about 5 ml of whole blood was collected via vena puncture with the help of a disposable syringe in between 8.00-9.00 am.
Glucose detected by enzymatic reaction (glucose oxidase and peroxidase = GOD-POD). 12 Different lipid fractions were estimated along with fasting plasma glucose. Serum total cholesterol was determined by an enzymatic (CHOD-PAP) colorimetric method, 13 triglycerides were determined by an enzymatic (GPO-PAP) method, 14 HDL-cholesterol was estimated by a precipitant method, 15 LDL-cholesterol was estimated by using Friedewald formula. 16 
L D L -ch o l e s t e r o l = To t a l ch o l e s t e r o l -( H D L cholesterol+triglycerides/5)
Serum analysis for fasting Na + , K + and Clwas performed by the automatic analyzer, ROCHE module Cobas 6000 (C-501 and C-601), and kits were procured by ROCHE.
Statistical analysis was carried out using standard deviation and chi-square test from which (P) value was derived. The P value <0.05 was considered to be signifi cant.
RESULTS
The mean ± SD age of patients was 39.98±3.91 (range 25-55) while the mean±SD of control was 40.02±1.41 (23-57) years. Out of 85 patients 45 (55%) were male and 40 (45%) were females. Among control subjects 25 (50%) for female and males, with mean of duration of the disease (10.2±5.9) years ( Table 1) .
Descriptive statistics of all diagnostic parameters on group I, II and III presented in Tables 2-4 . Table 2 show the mean total cholesterol, triglycerides, HDL-Cholesterol, LDL-Cholesterol and fasting blood sugar levels (group I), the patients in this group have NIDDM syndrome with normal values of lipid profi les. The mean levels of serum Na + (128.2±3.1 meq/L) were signifi cantly lower in the sera of NIDDM in comparison to the control subjects (140.09±2.33 meq/L), the mean level of K + (4.21±0.34 meq/L) show non signifi cance change in this group, while serum Cl -(110.16±5.54 meq/L) increased signifi cantly in the sera of NIDDM patients in comparison to that of control subjects (95.08±0.08 meq/L). Table 3 show the mean total cholesterol, triglycerides, HDL-Cholesterol, LDL-Cholesterol and fasting blood sugar levels (group II), the patients in this group have normal blood sugars with hyperlipidemia syndrome. The mean levels of serum Na + (118.2±3.13 meq/L) were signifi cantly lower in the sera of hyperlipedimia syndrome in comparison to the control subjects (140.09±2.33 meq/L), the mean level of K + (4.41±0.74 meq/L) show non signifi cance change in this group, while serum Cl -(89.26±0.54 meq/L) decreased significantly in the sera of hyperlipidemic patients in comparison to that of control subjects (95.08±0.08 meq/L). Table 4 show the mean total cholesterol, triglycerides, HDL-Cholesterol, LDL-Cholesterol and fasting blood sugar levels (group III), the patients in this group have 
DISCUSSION
The incidence of diabetes mellitus in the community is 5-10%. 17, 18 Diabetes mellitus damages every organ in the body, mainly the kidneys, leading to end-stage renal diseases. [19] [20] [21] The patients suffering from diabetes mellitus have disturbances in the electrolytes and in the acid-base balance. These distribution are caused by the diabetes (glucose balance), renal diseases and medications (diuretics and calcium channel blockers). 22 The potassium levels in IDDM and in NIDDM patients were reduced during periods of poor control of diabetes mellitus and increases when the blood glucose level are normal, 23 the levels of potassium were reduced because of diuretics 24 as well as due to diabetic keto acidosis (increased loss in urine). This explains the existence of hydrovolemia in these patients. We verifi ed the presence of hyperkalemia and because of this metabolic acidosis can occur frequently in these patients.
Diabetic usually take medication that influences the electrolyte balance. Thus, loop diuretics and thiazides may cause hyponatremia, hypokalemia and defi ciency of magnesium, disturbances in calcium handling (increased renal loss with loop diuretics and re absorption by thiaxides) and hyperglycemia. The treated NIDDM patients may continue to have mild hypertriglycridemia, increased intermediate-density lipoprotein levels, small dense lowdensity lipoprotein LDL with increased apolipoprotein B, and decreased HDL cholesterol levels. The central and abdominal distribution of adipose tissue in IDDM (insulin dependent diabetic mellitus) is associated with insulin resistance, hypertension, and the above lipoprotein abnormalities. Improvement in glucose control, in the absence of weight gain, leads to lower triglyceride and higher HDL cholesterol levels. In addition, the diabetic patient is prone to develop other defects that, in themselves, leading to hyperlipidemia, such as proteinuria, hypothyroidism and hypertension. 25 
